
Aspira Women's Health AWH
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Aspira Women's Health ROCE 2011-2026 | AWH
ROCE Jährlich Aspira Women's Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -486.78 | -108.03 | -136.17 | -155.11 | -134.21 | -213.6 | -273.98 | -109.31 | -99.77 | -32.73 | -173.15 | -151.62 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -32.73 | -486.78 | -172.87 |
ROCE Vierteljährlich Aspira Women's Health
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5733.49 | 5815.58 | 612.57 | 1237.16 | 1713.17 | 2413.1 | 683.58 | 606.82 | -94.52 | -971.09 | -177.49 | -202.66 | -151.07 | -110.1 | -53.65 | -97.7 | -116.58 | -138.71 | -122.51 | -166.57 | -166.59 | -176.49 | -135.89 | -172.84 | -165.74 | -158.85 | -118.97 | -192.32 | -228.72 | -255.2 | -220.16 | -312.27 | -331.03 | -362.14 | -322.22 | -351.53 | -288.74 | -216.4 | -81.23 | -110.26 | -109.97 | -111.21 | -78.64 | -87.3 | -66.93 | -45.98 | -26.29 | -75.53 | -116.12 | -186.86 | -174.27 | -217.97 | -212.43 | -187.8 | -140.66 | -43.7 | -54.03 | -42.93 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5815.58 | -971.09 | 173.56 |
ROCE anderer Aktien in der Diagnostik & Forschung
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Anixa Biosciences
ANIX
|
-77.18 | $ 3.01 | -2.9 % | $ 97.7 K | ||
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
1.9 | $ 38.55 | -1.56 % | $ 1.07 B | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
Brainsway Ltd.
BWAY
|
-17.75 | $ 23.6 | -1.87 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 33.99 | 1.34 % | $ 366 M | ||
|
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
-36.48 | $ 102.46 | 0.15 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
-6.52 | $ 26.04 | -0.78 % | $ 787 M | ||
|
BioNano Genomics
BNGO
|
-293.94 | $ 1.43 | -3.06 % | $ 1.82 M | ||
|
Guardant Health
GH
|
317.65 | $ 111.67 | 1.08 % | $ 13.7 B | ||
|
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-47.68 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
9.82 | $ 219.24 | -0.1 % | $ 160 B | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
42.0 | $ 65.81 | -1.3 % | $ 4.55 B | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
28.89 | $ 73.07 | -1.26 % | $ 28.2 B | ||
|
CareDx, Inc
CDNA
|
-77.82 | $ 20.32 | -2.31 % | $ 1.09 B | ||
|
NeoGenomics
NEO
|
-6.89 | $ 11.84 | -4.52 % | $ 1.5 B | ||
|
Celcuity
CELC
|
-97.97 | $ 109.58 | -2.27 % | $ 4.32 B | ||
|
DarioHealth Corp.
DRIO
|
-66.97 | $ 11.0 | 6.8 % | $ 312 M | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
Personalis
PSNL
|
-33.64 | $ 9.31 | -6.62 % | $ 552 M | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-35.1 | $ 145.86 | -2.56 % | $ 23.2 B | ||
|
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
36.29 | $ 229.99 | -2.33 % | $ 41.7 B | ||
|
Charles River Laboratories International
CRL
|
6.57 | $ 210.32 | -0.64 % | $ 10.8 B | ||
|
Thermo Fisher Scientific
TMO
|
14.8 | $ 581.3 | -1.83 % | $ 222 B | ||
|
Trinity Biotech plc
TRIB
|
0.08 | $ 0.84 | -5.23 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-28.81 | $ 39.99 | -3.82 % | $ 2.39 B | ||
|
Medpace Holdings
MEDP
|
54.13 | $ 582.34 | -1.81 % | $ 18 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.86 | $ 184.75 | 1.32 % | $ 20.5 B | ||
|
Biodesix
BDSX
|
-41.6 | $ 8.9 | -7.92 % | $ 1.15 B | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
-52.81 | $ 24.39 | 0.54 % | $ 31.7 M | ||
|
Laboratory Corporation of America Holdings
LH
|
13.5 | $ 269.85 | 0.01 % | $ 22.6 B | ||
|
Mettler-Toledo International
MTD
|
35.8 | $ 1 386.62 | -0.44 % | $ 29.4 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 178.39 | -4.03 % | $ 14.7 B | ||
|
IDEXX Laboratories
IDXX
|
50.7 | $ 673.89 | -0.42 % | $ 55.6 B |